These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8988154)

  • 21. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N; Kargili A; Akcay A; Kaya A
    Am J Kidney Dis; 2006 Oct; 48(4):e61-2. PubMed ID: 16997047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirtazapine: another drug responsible for drug-induced acute pancreatitis? A letter of warning.
    Lankisch PG; Werner HM
    Pancreas; 2003 Mar; 26(2):211. PubMed ID: 12604923
    [No Abstract]   [Full Text] [Related]  

  • 24. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 25. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens-Johnson syndrome due to mirtazapine - first case.
    Belkahia A; Hillaire-Buys D; Dereure O; Guillot B; Raison-Peyron N
    Allergy; 2009 Oct; 64(10):1554. PubMed ID: 19712123
    [No Abstract]   [Full Text] [Related]  

  • 27. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
    Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
    J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible mirtazapine-induced rhabdomyolysis.
    Khandat AB; Nurnberger JI; Shekhar A
    Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213
    [No Abstract]   [Full Text] [Related]  

  • 29. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
    Tulner DM; Smith OR; Schins A; de Jonge P; Quere M; Delanghe JR; Crijns HJ; den Boer JA; Korf J; Honig A
    Neuropsychobiology; 2011; 63(3):169-76. PubMed ID: 21228609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Edema tendency, dyspnea and hypertension in the treatment with mirtazapine (Remeron)].
    Jensen JB
    Ugeskr Laeger; 1999 May; 161(18):2699. PubMed ID: 10434798
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 32. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 33. Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
    Gray R
    Ment Health Care; 1998 Mar; 1(7):233-4. PubMed ID: 9791425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Mirtazapine in cancer patients.
    Van Gool AR; Bannink M; Stronks DL; Vos MS
    J Pain Symptom Manage; 2003 Jan; 25(1):7-8. PubMed ID: 12565183
    [No Abstract]   [Full Text] [Related]  

  • 35. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
    Stimmel GL; Dopheide JA; Stahl SM
    Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.
    de Boer T
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():19-23. PubMed ID: 8930006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLMD-like nocturnal movements with mirtazapine.
    Mattoo SK; Mahajan S; Sarkar S; Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e7-8. PubMed ID: 23273829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine-induced hyponatraemia.
    Roxanas MG
    Med J Aust; 2003 Oct; 179(8):453-4. PubMed ID: 14558878
    [No Abstract]   [Full Text] [Related]  

  • 39. No influence of dialysis on mirtazapine - a case report.
    Schlotterbeck PM; Vehren T; Milenovic S; Hiemke C; Kircher T; Leube D
    Pharmacopsychiatry; 2008 Nov; 41(6):259-60. PubMed ID: 19067265
    [No Abstract]   [Full Text] [Related]  

  • 40. Dysthymic disorder: treatment with mirtazapine.
    Dunner DL; Hendrickson HE; Bea C; Budech CB; O'Connor E
    Depress Anxiety; 1999; 10(2):68-72. PubMed ID: 10569129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.